人間のシトラートトランスポーターの構造と阻害機構 NaCT
David B Sauer1,2, Jinmei Song1,2, Bing Wang3
1Skirball Institute of Biomolecular Medicine, New York University School of Medicine, New York, NY, USA.
Nature
|February 18, 2021
まとめ
研究者は,阻害剤が脂肪酸合成を阻害する方法を理解するために,ナトリウム依存性シトラートトランスポーター (NaCT) の構造を決定した. これは潜在的な抗肥満薬のメカニズムと SLC13A5型に関する洞察を示しています
科学分野:
- 生物化学
- 構造生物学
- 分子輸送
背景:
- シトラートは重要な代謝中間物質であり,脂肪酸合成の調節剤である.
- 肝細胞のシトラート吸収は,潜在的な抗肥満薬標的であるナトリウム依存シトラートトランスポーター (NaCT) によって媒介されます.
- NaCTをコードするSLC13A5の変異は,新生児のを引き起こす.
研究 の 目的:
- 小分子阻害剤によるNaCT阻害の構造的基礎を解明する.
- NaCTがシトラート輸送を制御するメカニズムを理解する.
- 選択的なNACT阻害剤の開発とSLC13A5を理解するための構造的枠組みを提供すること.
主な方法:
- 人間のNACTの構造を決定するために,冷凍電子顕微鏡 (cryo-EM) が使用されました.
- シトラートと小分子阻害剤を併用したNaCTの構造が得られた.
- 同型トランスポーターとのNaCT構造の比較分析が行われました.
主要な成果:
- 凍結-EM構造は,抑制剤がシトラートと同じ部位に結合し,NaCT輸送サイクルを停止する方法を示しています.
- NaCT阻害剤の構造は,関連するディカルボキシラートトランスポーターに対する選択性を説明する.
- この構造は,NaCTの変異がどのようにを引き起こすかについての洞察を提供します.
結論:
- 決定されたNaCT構造は,シトラート輸送阻害の分子理解を提供します.
- これらの発見は,抗肥満療法のための改善された選択的なNaCT阻害剤の設計を容易にする.
- 構造データは,SLC13A5のの分子基礎を理解するのに役立ちます.
さらに関連する動画
関連する概念動画
Secondary Active Transport
8.7K
One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme "pump" embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
8.7K
Secondary Active Transport
133.8K
One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme “pump” embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
133.8K
The Citric Acid Cycle: Output
9.7K
The citric acid cycle is termed an amphibolic pathway as it operates both anabolically and catabolically. The cyclic reactions balance the flux of the substrates to provide an optimal concentration of NADH and ATP to the cell.
Regulation of Citric Acid Cycle
The citric acid cycle is regulated in several ways, including feedback inhibition, regulation of enzyme activities, and associated anaplerotic or cataplerotic pathways.
The primary substrate of the TCA cycle—acetyl CoA—is...
Regulation of Citric Acid Cycle
The citric acid cycle is regulated in several ways, including feedback inhibition, regulation of enzyme activities, and associated anaplerotic or cataplerotic pathways.
The primary substrate of the TCA cycle—acetyl CoA—is...
9.7K
The Significance of Membrane Transport
38.0K
The transport of solutes across the cell membrane is essential for metabolic processes, like maintaining cell size and volume, generating the action potential, exchanging nutrients and gases, etc. Membrane transport can be either passive or active. It can be simple diffusion, facilitated, or mediated transport aided by transport proteins such as transporters and channels.
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
38.0K
Enzyme Inhibition
88.6K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
88.6K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
769
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
769


